Dr. Vittorio Sebastiano is an Associate Professor of OGyN at Stanford School of Medicine, and the Woods Family Endowed Faculty Scholar in Pediatric Translational Medicine at the Stanford Maternal Child Health Research Institute. At his lab, Dr. Sebastiano and his team have spearheaded the development of a groundbreaking technology known as ERA (Epigenetic Reprogramming of Aging). This innovative approach leverages the concept of reprogramming to promote the epigenetic rejuvenation of adult cells while preserving their essential identity. Dr. Sebastiano’s pioneering work on ERA has garnered prestigious accolades such as the AFAR Junior Investigator Award and the Glenn Foundation Breakthrough in Gerontology Award and coverage from worldwide press like New York Times, National Geographic, Der Spiegel, The Times, Nature Biotechnology, France 2 “Envoyé spécial”. The patented ERA technology is currently being implemented by Turn Biotechnologies, a company co-founded by Dr. Sebastiano, where he serves as Chair of the SAB and Head of Research.